These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 16683135)

  • 1. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptide nucleic acids, efficient tools for molecular diagnosis (Review).
    Pellestor F; Paulasova P
    Int J Mol Med; 2004 Apr; 13(4):521-5. PubMed ID: 15010851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chirality and optical purity in nucleic acid recognition by PNA and PNA analogs.
    Sforza S; Galaverna G; Dossena A; Corradini R; Marchelli R
    Chirality; 2002 Jul; 14(7):591-8. PubMed ID: 12112334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glowing locked nucleic acids: brightly fluorescent probes for detection of nucleic acids in cells.
    Østergaard ME; Cheguru P; Papasani MR; Hill RA; Hrdlicka PJ
    J Am Chem Soc; 2010 Oct; 132(40):14221-8. PubMed ID: 20845923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
    Hatamoto M; Ohashi A; Imachi H
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):397-402. PubMed ID: 20135118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
    Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
    Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide nucleic acids as therapeutic agents.
    Nielsen PE
    Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical genosensor based on peptide nucleic acid-mediated PCR and asymmetric PCR techniques: Electrostatic interactions with a metal cation.
    Kerman K; Vestergaard M; Nagatani N; Takamura Y; Tamiya E
    Anal Chem; 2006 Apr; 78(7):2182-9. PubMed ID: 16579596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of PNA and LNA oligomers to chemotherapy.
    Elayadi AN; Corey DR
    Curr Opin Investig Drugs; 2001 Apr; 2(4):558-61. PubMed ID: 11566018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.
    Möhrle BP; Kumpf M; Gauglitz G
    Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) in biosensor development.
    Briones C; Moreno M
    Anal Bioanal Chem; 2012 Apr; 402(10):3071-89. PubMed ID: 22297860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics.
    Pellestor F; Paulasova P
    Eur J Hum Genet; 2004 Sep; 12(9):694-700. PubMed ID: 15213706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.
    Crinelli R; Bianchi M; Gentilini L; Palma L; Sørensen MD; Bryld T; Babu RB; Arar K; Wengel J; Magnani M
    Nucleic Acids Res; 2004; 32(6):1874-85. PubMed ID: 15051810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilabeled pyrene-functionalized 2'-amino-LNA probes for nucleic acid detection in homogeneous fluorescence assays.
    Hrdlicka PJ; Babu BR; Sørensen MD; Harrit N; Wengel J
    J Am Chem Soc; 2005 Sep; 127(38):13293-9. PubMed ID: 16173760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
    Kaihatsu K; Shah RH; Zhao X; Corey DR
    Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity and biotechnological aspects of peptide nucleic acid.
    Lundin KE; Good L; Strömberg R; Gräslund A; Smith CI
    Adv Genet; 2006; 56():1-51. PubMed ID: 16735154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA).
    Kaur H; Babu BR; Maiti S
    Chem Rev; 2007 Nov; 107(11):4672-97. PubMed ID: 17944519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.